Vascular Complications of Diabetes: Current Issues in Pathogenesis and Treatment, 2nd Edition
April 2008, Wiley-Blackwell
New features of this Second Edition include:
- Updated throughout to reflect the impact of recent major
clinical trials on current clinical practice
- Includes a major new section on diabetic neuropathy
- Revised section on diabetic retinopathy
Each chapter is short and succinct, focusing on ‘best practice’. There are key learning points at the end of each chapter, with numerous helpful tables, figures and clinical images.
List of contributors.
SECTION 1. MICRO- AND MACROVASCULAR COMPLICATIONS OF DIABETES.
Chatper 1. The burden of diabetes complications.
Chapter 2. Risk factors.
Chapter 3. Diabetic nephropathy.
Chapter 4. Coronary heart disease and diabetes.
Chapter 5. Diabetes and cerebrovascular disease.
Chapter 6. Erectile dysfunction.
Chapter 7. Evidence0based interventions to prevent or retard vascular complications.
SECTION 2. DIABETIC RETINOPATHY AND ASSOCIATED OPHTHALMIC DISORDERS.
Chapter 8. Diabetic retinpathy: epidemiology and risk factors.
Chapter 9. Classification and diagnosis of diabetic retinopathy.
Chapter 10. Pathogenesis of diabetic retinopathy.
Chapter 11. Diabetic maculopathy.
Chapter 12. Proliferative diabetic retinopathy.
Chapter 13. Non-retinal diabetic ocular complications.
Chapter 14. Pictorial case studies.
SECTION 3. DIABETIC NEUROPATHY.
Chapter 15. Diabetic neuropathy: epidemiology and risk factors.
Chapter 16. Classification and diagnosis of diabetic neuropathy.
Chapter 17. Pathogenesis of diabetic neuropathy.
Chapter 18. Treatment of diabetic neuropathy.
SECTION 4. PATHOGENESIS OF GLYCAEMIC VASCULAR DYSFUNCTION.
Chapter 19. Pathophysiological mechanisms.
Chapter 20. Protein kinase C.
Chapter 21. Protein kinase C activation and vascular permeability.
Chapter 22. Harmful effects of protein kinase C activation in cardiovascular and renal tissues.
Chapter 23. Therapeutic potential for isoform-selective protein kinase C inhibitors.